TGF-? plays a complex but critical role in bone. TGF-? inhibition of terminal osteoblast differentiation can result from its activation of the intracellular effector, SmadS, to bind and inhibit the function of Runx2, a critical transcriptional regulator of osteoblast differentiation. Preliminary data suggest that HDACs 4 and 5 are required for this repression. Specifically, the repression of Runx2 by Smad3/HDAC4/5 confers TGF-? inhibitory signals to osteocalcin and Runx2 expression, and to osteoblast differentiation in vitro. TGF-? repression of Runx2 function appears to be operative and important in vivo as well. The appearance of a cleidocranial dysplasia (CCD) phenotype in both Runx2 mice and mice over-expressing TGF-? in bone suggests that these molecules function in the same pathway to regulate craniofacial bone development in vivo, a hypothesis that will be tested in Aim 1. By crossing Runx2 mice with mice possessing mutations in TGF-? or HDAC function, we will also determine the ability of these pathways to modulate the severity of CCD. The extent to which TGF-? regulates Runx2-target gene expression through HDACs 4 and 5 in vivo will also be tested in Aim 1 using transgenic mice with specific defects in this signaling pathway. Understanding the molecular control of normal osteoblast differentiation in vivo will provide new insights into how this differentiation pathway can be manipulated. As TGF-? and Runx2 regulate the expression of many components of the bone matrix, the intersection of these pathways may affect the mechanical quality of bone matrix. Preliminary data suggest that partial reduction of TGF-? signaling increases several functionally relevant properties of bone, including intrinsic mechanical properties, mineral concentration, cortical thickness, trabecular bone volume, and resistance to fracture. These conclusions were derived by the novel combined application of atomic force microscopy (AFM) with nanoindenting capability, micro-Raman spectroscopy, X-ray tomographic microscopy (XTM), and 3-point bending to study bone in transgenic mice.
In Aim 2, these methods will be used to determine if genetic disruption of the downstream targets of TGF-?, HDACS and Runx2, can also affect these bone properties.
In Aim 3, the hypothesis that TGF-? regulation of bone matrix mechanical properties and composition is Runx2 and HDAC4/5-dependent will be tested directly by evaluating the bone quality of crossed mice (i.e. Runx2 X HDAC5-/-) generated in Aim1. These studies may lead to identification of targets that can be therapeutically manipulated to promote formation of high-quality bone to repair developmental or post-surgical defects in craniofacial bone. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Small Research Grants (R03)
Project #
1R03DE016868-01A1
Application #
7090933
Study Section
NIDCR Special Grants Review Committee (DSR)
Program Officer
Shum, Lillian
Project Start
2006-03-01
Project End
2008-02-28
Budget Start
2006-03-01
Budget End
2007-02-28
Support Year
1
Fiscal Year
2006
Total Cost
$76,417
Indirect Cost
Name
University of California San Francisco
Department
Anatomy/Cell Biology
Type
Schools of Dentistry
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Jáuregui, Emmanuel J; Akil, Omar; Acevedo, Claire et al. (2016) Parallel mechanisms suppress cochlear bone remodeling to protect hearing. Bone 89:7-15
Chang, Jolie L; Brauer, Delia S; Johnson, Jacob et al. (2010) Tissue-specific calibration of extracellular matrix material properties by transforming growth factor-? and Runx2 in bone is required for hearing. EMBO Rep 11:765-71
Ionova-Martin, S S; Do, S H; Barth, H D et al. (2010) Reduced size-independent mechanical properties of cortical bone in high-fat diet-induced obesity. Bone 46:217-25
Thurner, Philipp J; Chen, Carol G; Ionova-Martin, Sophi et al. (2010) Osteopontin deficiency increases bone fragility but preserves bone mass. Bone 46:1564-73
Mohammad, Khalid S; Chen, Carol G; Balooch, Guive et al. (2009) Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS One 4:e5275
Butcher, Darci T; Alliston, Tamara; Weaver, Valerie M (2009) A tense situation: forcing tumour progression. Nat Rev Cancer 9:108-22
Saeki, Kuniko; Hilton, Joan F; Alliston, Tamara et al. (2007) Elevated TGF-beta2 signaling in dentin results in sex related enamel defects. Arch Oral Biol 52:814-21